Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRG-HN009 cisplatin dosing schedule with radiation in locoregionally advanced SCCHN
2022-004130-19Phase 2Active
- Sponsor
- Cancer Trials Ireland
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Cancer Trials Ireland. Started Jan 2023; status: active.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2022-004130-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-004130-19.